Zivo Bioscience (OTCMKTS:ZIVO) and Nomad Foods (NYSE:NOMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.
This table compares Zivo Bioscience and Nomad Foods’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
0.1% of Zivo Bioscience shares are owned by institutional investors. Comparatively, 73.2% of Nomad Foods shares are owned by institutional investors. 33.2% of Zivo Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Risk & Volatility
Zivo Bioscience has a beta of 2.35, indicating that its share price is 135% more volatile than the S&P 500. Comparatively, Nomad Foods has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.
This is a breakdown of recent ratings and target prices for Zivo Bioscience and Nomad Foods, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Nomad Foods has a consensus target price of $22.00, indicating a potential upside of 14.05%. Given Nomad Foods’ higher probable upside, analysts plainly believe Nomad Foods is more favorable than Zivo Bioscience.
Valuation and Earnings
This table compares Zivo Bioscience and Nomad Foods’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Zivo Bioscience||N/A||N/A||-$10.03 million||N/A||N/A|
|Nomad Foods||$2.21 billion||1.52||$154.28 million||$1.13||17.07|
Nomad Foods has higher revenue and earnings than Zivo Bioscience.
Nomad Foods beats Zivo Bioscience on 8 of the 10 factors compared between the two stocks.
Zivo Bioscience Company Profile
Zivo Bioscience, Inc., together with its subsidiaries, focuses on the research and identification of natural bioactive ingredients derived from its proprietary algal cultures. The company intends to license and sell its natural bioactive ingredients to animal, food, dietary supplement, and medical food manufacturers; and license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that allow individuals to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to Zivo Bioscience, Inc. in November 2014. Zivo Bioscience, Inc. is headquartered in Keego Harbor, Michigan.
Nomad Foods Company Profile
Nomad Foods Limited manufactures and distributes frozen foods in Western Europe. The company offers fish products, including fish fingers, coated fish, and natural fish; vegetables, such as peas and spinach; and poultry and meat products comprising nuggets, grills, and burgers. It also provides meals products that include ready to cook noodles, pasta, lasagne, pancakes, and other ready-made meals; and other products, such as soups, pizzas, and bakery goods. The company sells its products to supermarkets and food retail chains directly or through distribution arrangements primarily under the Birdseye, Findus, and Iglo brands. Nomad Foods Limited is based in Feltham, the United Kingdom.
Receive News & Ratings for Zivo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zivo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.